# US 2017/0281511 A1 · Compositions, kits and methods for maintaining eyelid hygiene

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281511 A1
- Document ID: US20170281511A1
- Status: Published application
- Kind: A1
- Application number: 15/090,386
- Filed: 2016-04-04
- Published: 2017-10-05
- Earliest claimed: 2016-04-04
- Assignees: OCuSOFT, Inc.
- Applicants: OCuSOFT, Inc.
- Inventors: Nat Adkins, JR.; Cynthia Barratt
- Web page: https://patentgrep.com/patent/US20170281511A1

## CPC

- A61K 8/68: Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
- A61K 8/046: {Aerosols; Foams}
- A61K 8/20: Halogens; Compounds thereof
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/42: Amides
- A61K 8/442: {substituted by amido group(s)}
- A61K 8/4973: {with oxygen as the only hetero atom}
- A61K 8/553: {Phospholipids, e.g. lecithin}
- A61K 8/602: {Glycosides, e.g. rutin}
- A61K 8/86: Polyethers
- A61K 8/88: Polyamides
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 33/20: Elemental chlorine; Inorganic compounds releasing chlorine
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61P 27/02: Ophthalmic agents
- A61Q 19/005: {Preparations for sensitive skin}
- A61Q 19/007: {Preparations for dry skin}
- A61Q 19/10: Washing or bathing preparations
- A61K 2800/49: Solubiliser, Solubilising system
- A61K 2800/524: Preservatives
- A61K 2800/87: Application Devices; Containers; Packaging
- A61K 2800/884: Sequential application
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Compositions and methods for cleansing the eyelid and treating an ocular condition are disclosed herein. A method for treating an ocular condition involves cleansing an eyelid with a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride followed by applying a therapeutically effective amount of a second ophthalmic composition to a margin of the eyelid, wherein the second ophthalmic composition consists essentially of water and hypochlorous acid.

## Claims

### Claim 1

A first ophthalmic composition comprising:
a preservative blend, the preservative blend consisting essentially of a mixture of polyaminopropyl biguanide, a 1,2-glycol and a sphingoid lipid;
a surfactant solution; and
a moisturizer,
wherein the sphingoid lipid comprises salicyloyl phytosphingosine.

### Claim 2 (depends on 1)

The first ophthalmic composition according to claim 1, wherein the 1,2-glycol is selected from the group consisting of 1,2-hexanediol, caprylyl glycol, pentylene glycol and mixtures thereof.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The first ophthalmic composition according to claim 1, wherein the salicyloyl phytosphingosine is present in a concentration ranging from 0.01 to 1 weight % based on the total weight of the composition.

### Claim 5 (depends on 1)

The first ophthalmic composition according to claim 1, wherein the surfactant solution comprises an aqueous mixture of a nonionic surfactant and at least one of an amphoteric or an anionic surfactant.

### Claim 6 (depends on 5)

The first ophthalmic composition according to claim 5, wherein the surfactant solution consists essentially of water, sodium chloride, potassium chloride, calcium chloride, disodium cocoamphodiacetate, PEG-80 sorbitan laurate and decyl glucoside.

### Claim 7 (depends on 1)

The first ophthalmic composition according to claim 1, wherein the moisturizer is selected from the group consisting of methyl gluceth-20, sorbital, glycerine, propylene glycol, panthenol, D-panthenol, and D, L-panthenol and mixtures thereof.

### Claim 8 (depends on 1)

The first ophthalmic composition according to claim 1, further comprising a foam stabilizer.

### Claim 9 (depends on 8)

The first ophthalmic composition according to claim 8, wherein the foam stabilizer comprises PEG-120 methyl glucose dioleate.

### Claim 10 (depends on 1)

The first ophthalmic composition according to claim 1, wherein the first ophthalmic composition is a foam.

### Claim 11

A first ophthalmic composition consisting essentially of: water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride.

### Claim at position 12

-17. (canceled)

### Claim 18

A kit for maintaining eyelid hygiene consisting essentially of:
a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride;
a pharmaceutically acceptable container for containing the first ophthalmic composition; and
an applicator for applying the first ophthalmic composition to an eyelid.

### Claim 19 (depends on 18)

The kit according to claim 18, wherein the first ophthalmic composition has a volume of 25 ml to 100 ml.

### Claim 20 (depends on 18)

The kit according to claim 18, wherein the applicator comprises a plurality of fabric pads.
